Elliptic Laboratories ASA (ELABS.OL)
NOK 8.8
(-5.38%)
NOK 8.8
(-5.38%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -42.81 Million | -12.75 Million | -10.82 Million | -6.67 Million | -8.04 Million | -35.15 Million |
| Net Income | -38 Million | -39.3 Million | -13.09 Million | -15.55 Million | -16.96 Million | -33.23 Million |
| Depreciation & Amortization | 4.63 Million | 11.31 Million | 8.31 Million | 5.43 Million | 4.39 Million | 2.11 Million |
| Deferred income taxes | - | - | -12 Thousand | -548.79 Thousand | -431.32 Thousand | -380.44 Thousand |
| Stock-based compensation | 9.84 Million | 12.46 Million | 10.34 Million | 4.03 Million | 2.87 Million | 3.71 Million |
| Change in working capital | -20.32 Million | 1.44 Million | -17.03 Million | -2.21 Million | -670.78 Thousand | -9.14 Million |
| Other non-cash items | 38.08 Million | 1.31 Million | 653 Thousand | 2.16 Million | 2.75 Million | 1.76 Million |
| Investing Cash Flow | -25.61 Million | -23.32 Million | -17.61 Million | -15.1 Million | -11.09 Million | -8.73 Million |
| Investments in PPE | -25.61 Million | -23.32 Million | -17.61 Million | -15.1 Million | -11.09 Million | -8.73 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -20.45 Million | - | - | - | - | - |
| Financing Cash Flow | 4.15 Million | -4.26 Million | 146.8 Million | 87.19 Million | 38.38 Million | 23.23 Million |
| Debt repayment | -4 Million | -4 Million | -4 Million | -25 Million | - | -25 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 9.49 Million | 2.97 Million | 162.21 Million | 125.04 Million | 43.01 Million | - |
| Other Financing Activities | 3.66 Million | -3.23 Million | -11.41 Million | -12.85 Million | -4.62 Million | 23.23 Million |
| Accounts receivables | -20.11 Million | -11.46 Million | -28.59 Million | -450.8 Thousand | -741.64 Thousand | -10.55 Million |
| Accounts payables | 2.18 Million | -1.36 Million | 2.04 Million | 154.08 Thousand | -1.69 Million | 1.42 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -2.39 Million | 14.27 Million | 9.52 Million | -1.92 Million | 1.76 Million | -11.36 Thousand |
| Cash at beginning of period | 178.21 Million | 218.15 Million | 99.72 Million | 34.36 Million | 16.62 Million | 37.33 Million |
| Cash at end of period | 115.58 Million | 178.21 Million | 218.15 Million | 99.72 Million | 35.87 Million | 16.62 Million |
| Capital Expenditure | -25.61 Million | -23.32 Million | -17.61 Million | -15.1 Million | -11.09 Million | -8.73 Million |
| Effect of forex changes on cash | 1.63 Million | 416 Thousand | 59 Thousand | -47.26 Thousand | 5059.00 | -57.75 Thousand |
| Net cash flow / Change in cash | -62.63 Million | -39.93 Million | 118.42 Million | 65.36 Million | 19.24 Million | -20.71 Million |
| Free Cash Flow | -68.42 Million | -36.08 Million | -28.43 Million | -21.78 Million | -19.14 Million | -43.89 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 4.75 Million | -2.61 Million | -20.17 Million | -38 Million | -8.61 Million | 6.01 Million |
| Depreciation & Amortization | 8.52 Million | 1.42 Million | 1.4 Million | 4.63 Million | 4.45 Million | 3.74 Million |
| Deferred income taxes | - | - | - | - | 9000.00 | 1000.00 |
| Stock-based compensation | 1.36 Million | 1.8 Million | 1.42 Million | 9.84 Million | 1.66 Million | 3.75 Million |
| Change in working capital | -13.79 Million | -7.27 Million | 19.74 Million | -20.32 Million | -9.31 Million | -25.68 Million |
| Other non-cash items | 1.09 Million | 12.49 Million | -16.5 Million | 38.08 Million | 141 Thousand | 147 Thousand |
| Investing Cash Flow | -6.46 Million | -7.25 Million | -6.54 Million | -25.61 Million | -6.34 Million | -6.63 Million |
| Investments in PPE | -8.02 Million | -7.25 Million | -6.54 Million | -25.61 Million | -6.34 Million | -6.63 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -6.46 Million | -1000.00 | 1000.00 | - | - | - |
| Financing Cash Flow | 1.77 Million | -2.89 Million | 3.37 Million | 4.15 Million | 4 Million | -1.83 Million |
| Debt repayment | -1.51 Million | -1 Million | -1 Million | -4 Million | -1 Million | -1 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 4.83 Million | - | 2.98 Million | 9.49 Million | 6.51 Million | - |
| Other Financing Activities | 3.28 Million | - | 3.66 Million | 3.66 Million | -1.51 Million | -832 Thousand |
| Accounts receivables | -9.92 Million | -8.65 Million | 16.11 Million | -20.11 Million | -11.4 Million | -24.12 Million |
| Accounts payables | 2.58 Million | -75 Thousand | 173 Thousand | 2.18 Million | 2.06 Million | 594 Thousand |
| Inventory | - | - | 1.00 | - | -1000.00 | - |
| Other working capital | -3.86 Million | 1.45 Million | 3.45 Million | -2.39 Million | 23 Thousand | -2.15 Million |
| Cash at beginning of period | 99.92 Million | 115.58 Million | 119.52 Million | 178.21 Million | 133.6 Million | 153.95 Million |
| Cash at end of period | 96.89 Million | 99.92 Million | 115.58 Million | 115.58 Million | 119.52 Million | 133.6 Million |
| Capital Expenditure | -8.02 Million | -7.25 Million | -6.54 Million | -25.61 Million | -6.34 Million | -6.63 Million |
| Effect of forex changes on cash | -270 Thousand | 2.05 Million | 1.27 Million | 1.63 Million | -71 Thousand | 141 Thousand |
| Net cash flow / Change in cash | -3.03 Million | -15.65 Million | -3.94 Million | -62.63 Million | -14.07 Million | -20.35 Million |
| Free Cash Flow | -6.09 Million | -14.81 Million | -8.58 Million | -68.42 Million | -18 Million | -18.66 Million |
IRBT
TRGP
4828
WPIL
603906
ACEYY